AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm’s AI model of the immune ...

IT services major Accenture unveiled a $4 billion share buyback on Thursday, closing the fourth quarter with ...

Careful compliance is among the non-negotiables for building customer trust in banks; tech sprawl runs a real risk of harming ...

Scope 3 emissions represent a significant challenge for companies aiming to enhance their ESG performance. But because ...

Global businesses focussed on sustainability need to empower local communities to take local action as this results in more ...